- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Pancreatic Neuroendocrine Neoplasm in South Africa
Total 6753 results
-
Erasmus Medical CenterRecruitingNeuroendocrine Tumors | Peptide Receptor Radionuclide TherapyNetherlands
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingPancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreatic Intraductal Papillary-Mucinous Neoplasm | Stage I Pancreatic Cancer AJCC v6 and v7 | Stage II Pancreatic Cancer AJCC v6 and v7United States, Canada, Israel, Belgium
-
Lipotek Pty LtdRoyal Adelaide Hospital; Trident Clinical Research Pty LtdCompleted
-
Stanford UniversityCompletedPancreatic CancerUnited States, Canada
-
University of ChicagoNational Cancer Institute (NCI)CompletedPancreatic CancerUnited States
-
ChimerixTranslational Drug DevelopmentTerminatedMetastatic Pancreatic CancerUnited States
-
NewLink Genetics CorporationCompletedMetastatic Pancreatic Adenocarcinoma | Metastatic Pancreatic CancerUnited States
-
Prisma Health-UpstateOncolix, Inc.Terminated
-
Eli Lilly and CompanyTerminatedMetastatic Pancreatic CancerUnited States
-
Hoffmann-La RocheCompletedColorectal CancerSouth Africa
-
Medical University of South CarolinaTerminated
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyTerminatedPancreatic Adenocarcinoma | Stage III Pancreatic CancerUnited States
-
Astex Pharmaceuticals, Inc.TerminatedPancreatic CancerUnited States
-
University of StellenboschUnknown
-
Eli Lilly and CompanyCompletedMetastatic Pancreatic CancerUnited States, Spain, Germany
-
Boston Scientific CorporationCompletedPancreatic CarcinomaAustralia, France, Japan, Belgium, Hong Kong, Italy, China, India, United States
-
Melanoma and Skin Cancer Trials LimitedRecruitingMetastatic Merkel Cell CarcinomaAustralia
-
Royal Liverpool University HospitalNCIC Clinical Trials Group; Australasian Gastro-Intestinal Trials GroupCompletedPancreatic CancerFrance, Australia, Canada, Sweden, Switzerland, Finland, Japan, Germany, United Kingdom, Italy, Czech Republic, Greece, Hungary
-
Société des Produits Nestlé (SPN)CompletedExocrine Pancreatic InsufficiencyAustralia, New Zealand
-
SCRI Development Innovations, LLCAchieve Life SciencesCompletedPancreatic CancerUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedPerifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic CancerPancreatic CancerUnited States
-
Melanoma Institute AustraliaNovartisRecruiting
-
Tragara Pharmaceuticals, Inc.CompletedPancreatic Cancer | Metastatic Pancreatic CancerUnited States
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLCNot yet recruitingMucosal MelanomaAustralia
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedPancreatic CancerUnited States
-
Jazz PharmaceuticalsCompletedAdvanced Solid Tumor | Metastatic Solid Tumor | Urothelial Cancer | Poorly Differentiated Neuroendocrine Carcinomas | Homologous Recombination Deficient-Positive Malignancies AgnosticUnited States
-
Boston University Charles River CampusMassachusetts General Hospital; University of Witwatersrand, South AfricaNot yet recruitingCervical Cancer | HivUnited States, South Africa
-
Pharmexa A/SSyneos Health; ICON Clinical Research; ORION Clinical Services; CIRION Central... and other collaboratorsTerminatedAdvanced Unresectable Pancreatic CancerUnited States, Spain, Australia, Netherlands, Belgium, Denmark, France, Ireland, Italy, Norway, Poland, Sweden
-
QBiotics Group LimitedMerck Sharp & Dohme LLCTerminated
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruiting
-
University of Cape TownCompletedIron Deficiency Anemia of PregnancySouth Africa
-
Provectus PharmaceuticalsCompleted
-
ITM Solucin GmbHABX CRO; PSI CROActive, not recruitingNeuroendocrine TumorsGermany, France, United States, United Kingdom, Australia, Italy, Belgium, Switzerland, Czechia, Spain, Austria, Netherlands, Poland, South Africa
-
Gilead SciencesWithdrawnPancreatic Cancer | Metastatic Pancreatic Adenocarcinoma | Metastatic Pancreatic CancerUnited States
-
Bristol-Myers SquibbActive, not recruiting
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia, Brazil, Spain, South Africa, Ukraine, Bosnia and Herzegovina
-
AbbVieTerminatedGlioblastoma | Medullary Thyroid Cancer | Malignant Melanoma | Other Solid Tumors | Large-Cell Neuroendocrine Carcinoma | Neuroendocrine Prostate Cancer | High Grade Gastroenteropancreatic Neuroendocrine Carcinoma | Other Neuroendocrine CarcinomaUnited States
-
Melanoma and Skin Cancer Trials LimitedTrans Tasman Radiation Oncology GroupActive, not recruiting
-
QBiotics Group LimitedTerminated
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLCActive, not recruitingMelanoma Stage IIIAustralia
-
GlaxoSmithKlineCompletedParkinson DiseaseGermany, South Africa
-
Pharmacyclics LLC.CompletedPancreatic Cancer | Exocrine Pancreatic Cancer | Ductal AdrenocarcinomaUnited States
-
AbbVieTerminatedExocrine Pancreatic Insufficiency (EPI)United States
-
CelgeneCompletedPancreatic CancerUnited States, Canada, Spain, Australia, France, Germany, Austria, Italy, Ukraine
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLC; NovartisActive, not recruiting
-
Provectus PharmaceuticalsCompleted
-
National Cancer Institute (NCI)RecruitingAdvanced Extrapulmonary Neuroendocrine Carcinoma | Metastatic Extrapulmonary Neuroendocrine Carcinoma | Recurrent Extrapulmonary Neuroendocrine Carcinoma | Unresectable Extrapulmonary Neuroendocrine CarcinomaUnited States
-
Anthony Joshua, FRACPSt Vincent's Hospital, SydneyActive, not recruiting
-
Hoffmann-La RocheCompletedPancreatic CancerBelgium, France, Germany, Italy, Spain, Australia, Canada, Czech Republic, Singapore, New Zealand, Austria, China, Netherlands, South Africa, United Kingdom, Israel, Peru, Finland, Poland, Taiwan, Sweden
-
Point TherapeuticsTerminatedAdenocarcinoma | Neoplasm Metastasis | Pancreatic CancerUnited States